TLSI Q1 2023 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3M+25.9% YoY

Gross Profit

$2M77.8% margin

Operating Income

-$10M-339.2% margin

Net Income

-$8M-277.1% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

-7.5%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$74,000

Balance Sheet

Total Assets

$20M

Total Liabilities

$24M

Stockholders' Equity

-$4M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+25.9%
Gross Profit	$2M	$2M	+16.4%
Operating Income	-$10M	-$8M	-28.3%
Net Income	-$8M	-$8M	-5.0%